TPI1 and frontotemporal dementia: The underlying mechanism of action of FTD/TPI is characterized by FTD substitution of thymidine in DNA, leading to impaired DNA function [7,8,9] and the prevention of FTD degradation by TPI, thereby augmenting the bioavailability of FTD [10].